Cargando…
tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9
CRISPR-interference (CRISPRi), a highly effective method for silencing genes in mammalian cells, employs an enzymatically dead form of Cas9 (dCas9) complexed with one or more guide RNAs (gRNAs) with 20 nucleotides (nt) of complementarity to transcription initiation sites of target genes. Such gRNA/d...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495392/ https://www.ncbi.nlm.nih.gov/pubmed/37696787 http://dx.doi.org/10.1038/s41467-023-40836-3 |
_version_ | 1785104884645756928 |
---|---|
author | Auradkar, Ankush Guichard, Annabel Kaduwal, Saluja Sneider, Marketta Bier, Ethan |
author_facet | Auradkar, Ankush Guichard, Annabel Kaduwal, Saluja Sneider, Marketta Bier, Ethan |
author_sort | Auradkar, Ankush |
collection | PubMed |
description | CRISPR-interference (CRISPRi), a highly effective method for silencing genes in mammalian cells, employs an enzymatically dead form of Cas9 (dCas9) complexed with one or more guide RNAs (gRNAs) with 20 nucleotides (nt) of complementarity to transcription initiation sites of target genes. Such gRNA/dCas9 complexes bind to DNA, impeding transcription of the targeted locus. Here, we present an alternative gene-suppression strategy using active Cas9 complexed with truncated gRNAs (tgRNAs). Cas9/tgRNA complexes bind to specific target sites without triggering DNA cleavage. When targeted near transcriptional start sites, these short 14–15 nts tgRNAs efficiently repress expression of several target genes throughout somatic tissues in Drosophila melanogaster without generating any detectable target site mutations. tgRNAs also can activate target gene expression when complexed with a Cas9-VPR fusion protein or modulate enhancer activity, and can be incorporated into a gene-drive, wherein a traditional gRNA sustains drive while a tgRNA inhibits target gene expression. |
format | Online Article Text |
id | pubmed-10495392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-104953922023-09-13 tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9 Auradkar, Ankush Guichard, Annabel Kaduwal, Saluja Sneider, Marketta Bier, Ethan Nat Commun Article CRISPR-interference (CRISPRi), a highly effective method for silencing genes in mammalian cells, employs an enzymatically dead form of Cas9 (dCas9) complexed with one or more guide RNAs (gRNAs) with 20 nucleotides (nt) of complementarity to transcription initiation sites of target genes. Such gRNA/dCas9 complexes bind to DNA, impeding transcription of the targeted locus. Here, we present an alternative gene-suppression strategy using active Cas9 complexed with truncated gRNAs (tgRNAs). Cas9/tgRNA complexes bind to specific target sites without triggering DNA cleavage. When targeted near transcriptional start sites, these short 14–15 nts tgRNAs efficiently repress expression of several target genes throughout somatic tissues in Drosophila melanogaster without generating any detectable target site mutations. tgRNAs also can activate target gene expression when complexed with a Cas9-VPR fusion protein or modulate enhancer activity, and can be incorporated into a gene-drive, wherein a traditional gRNA sustains drive while a tgRNA inhibits target gene expression. Nature Publishing Group UK 2023-09-11 /pmc/articles/PMC10495392/ /pubmed/37696787 http://dx.doi.org/10.1038/s41467-023-40836-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Auradkar, Ankush Guichard, Annabel Kaduwal, Saluja Sneider, Marketta Bier, Ethan tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9 |
title | tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9 |
title_full | tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9 |
title_fullStr | tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9 |
title_full_unstemmed | tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9 |
title_short | tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9 |
title_sort | tgcrispri: efficient gene knock-down using truncated grnas and catalytically active cas9 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495392/ https://www.ncbi.nlm.nih.gov/pubmed/37696787 http://dx.doi.org/10.1038/s41467-023-40836-3 |
work_keys_str_mv | AT auradkarankush tgcrispriefficientgeneknockdownusingtruncatedgrnasandcatalyticallyactivecas9 AT guichardannabel tgcrispriefficientgeneknockdownusingtruncatedgrnasandcatalyticallyactivecas9 AT kaduwalsaluja tgcrispriefficientgeneknockdownusingtruncatedgrnasandcatalyticallyactivecas9 AT sneidermarketta tgcrispriefficientgeneknockdownusingtruncatedgrnasandcatalyticallyactivecas9 AT bierethan tgcrispriefficientgeneknockdownusingtruncatedgrnasandcatalyticallyactivecas9 |